Mayukh Sukhatme
CFO
CFO
Board Member
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Roivant Sciences Ltd. (ROIV) | President and Chief Investment Officer | $550,000 | $1,276,655 |
| 2024 | Roivant Sciences Ltd. (ROIV) | President and Chief Investment Officer | $550,000 | $251,858,764 |
| 2023 | Roivant Sciences Ltd. (ROIV) | President and Chief Investment Officer | $550,000 | $574,560 |
| 2022 | Roivant Sciences Ltd. (ROIV) | President and Chief Investment Officer | $450,000 | $48,925,582 |
| 2021 | Roivant Sciences Ltd. (ROIV) | President and Chief Investment Officer | $450,000 | $17,488,425 |
Earnings-call appearances
-
Roivant Sciences Ltd. Q1 FY2024 Earnings Call2023-08-14
Roivant Sciences Ltd. (ROIV)
-
Roivant Sciences Ltd. Q3 FY2023 Earnings Call2023-02-01
Roivant Sciences Ltd. (ROIV)
-
Roivant Sciences Ltd. Q1 FY2023 Earnings Call2022-08-15
Roivant Sciences Ltd. (ROIV)